BackRevolution Healthcare Acquisition Overview

Revolution Healthcare Acquisition EBIT

Track Revolution Healthcare Acquisition's EBIT ($-800B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$671.59K
↑ 7.56% YoY

As of Sep 30, 2022

Annual EBIT (TTM)

-$797.85B

Trailing 12 months ending Sep 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Revolution Healthcare Acquisition (REVH) FAQ

As of the most recent data (September 2022), REVH shows a EBIT of $-800B. That is below the sector sector average of $-63M. Scroll down for historical charts and peer comparison views.

The its sector sector average EBIT is about $-63M. Revolution Healthcare Acquisition is at $-800B, which is lower that average. That is roughly 1274712.9% below the sector mean. Use the comparison chart on this page to see how REVH stacks up against individual peers as well.

Tracking REVH's ebit over time shows whether Revolution Healthcare Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $-800B Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Revolution Healthcare Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-800B) with ownership activity and broader fundamentals.